Advancing regulatory science in US FDA draft plan for 2011-2015
This article was originally published in SRA
Executive Summary
A key area of focus for the US Food and Drug Administration in the near future will be to advance regulatory science in all aspects of its work, commissioner Margaret Hamburg has said in a draft report that lists the agency's strategic priorities for fiscal years 2011-151,2.